Postmastectomy Radiation in HER-2 Positive Breast Cancer after Neoadjuvant Therapy: Secondary Analysis of Two Randomized Trials

被引：0
|
作者：
Zeidan, Y. [1 ]
Saifi, O. [2 ]
Bachir, B. [3 ]
Panoff, J. E. [4 ]
Poortmans, P. [5 ]
机构：
[1] Lynn Canc Inst, Baptist Hlth South Florida, Boca Raton, FL USA
[2] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL USA
[3] Amer Univ, Beirut Med Ctr, Beirut, Lebanon
[4] Baptist Hlth South Florida, Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA
[5] lridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2461
引用
收藏
页码：E216 / E216
页数：1
相关论文
共 50 条
  • [1] Pathological Response and Survival after Neoadjuvant Therapy for Her-2 Positive Breast Cancer
    Jinga, Dan Corneliu
    Jinga, Maria Ruxandra
    Miron, Adrian
    Noditi, Aniela
    Blidaru, Alexandru
    CHIRURGIA, 2021, 116 (02) : S91 - S97
  • [2] Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials
    Saifi, Omran
    Bachir, Bachir
    Panoff, Joseph
    Poortmans, Philip
    Zeidan, Youssef H.
    RADIOTHERAPY AND ONCOLOGY, 2023, 184
  • [3] Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer
    Lattoni, E.
    Omarini, C.
    Tamma, A. V.
    Noventa, S.
    Orsi, G.
    Piacentini, F.
    Moscetti, L.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials
    Brollo, Janaina
    Curigliano, Giuseppe
    Disalvatore, Davide
    Marrone, Bianca Fontana
    Criscitiello, Carmen
    Bagnardi, Vincenzo
    Kneubil, Maximiliano Cassilha
    Fumagalli, Luca
    Locatelli, Marzia
    Manunta, Silvia
    Goldhirsch, Aron
    CANCER TREATMENT REVIEWS, 2013, 39 (01) : 44 - 50
  • [5] Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials
    Guarneri, V
    Griguolo, G.
    Miglietta, F.
    Conte, P. F.
    Dieci, M., V
    Girardi, F.
    ESMO OPEN, 2022, 7 (02)
  • [6] Evaluation of clinical and pathological responses of HER-2 positive locally advanced breast cancer patients after neoadjuvant therapy and surgery
    Bayram, Ertugrul
    Mete, Burak
    Kahramanoglu, Pakize Irem
    Melekoglu, Ebru
    Turker, Mehmet
    Kara, Oguz
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (03): : 1062 - 1071
  • [7] Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab
    Bachir, B.
    Anouti, S.
    Jaoude, J. Abi
    Kayali, M.
    Tfayli, A.
    De Azambuja, E.
    Poortmans, P.
    Zeidan, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S7 - S7
  • [8] De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or not to Boost?
    Kayali, M.
    Jaoude, J. Abi
    Tamim, H.
    Makki, M.
    Tfaily, A.
    El Saghir, N.
    Assi, H.
    De Azambuja, E.
    Poortmans, P.
    Geara, F. B.
    Zeidan, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S27 - S27
  • [9] De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or Not to Boost?
    Jaoude, Joseph Abi
    Kayali, Majd
    de Azambuja, Evandro
    Makki, Maha
    Tamim, Hani
    Tfayli, Arafat
    El Saghir, Nagi
    Geara, Fady
    Piccart, Martine
    Poortmans, Philip
    Zeidan, Youssef H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 1040 - 1046
  • [10] Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients
    Vici, P.
    Viola, G.
    Botti, C.
    Rossi, S.
    Vitucci, C.
    Corsetti, S.
    Di Lauro, L.
    Sergi, D.
    Foggi, P.
    Perri, P.
    Tirellil, C.
    Mottolese, M.
    Fattoruso, S. I. S.
    Lopez, M.
    CLINICA TERAPEUTICA, 2008, 159 (06): : 449 - 452
12345